We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
TransUnion
TRU
$15.3B
| $23.1M | 0.06% |
265,000
+15,000
| +6% | +$1.2M |
|
352
Nexstar Media Group
NXST
$5.8B
| $23M | 0.06% |
+275,000
| New | +$20.7M |
|
353
Best Buy
BBY
$17.8B
| $23M | 0.06% |
263,500
+3,800
| +1% | +$288K |
|
354
AvalonBay Communities
AVB
$27.1B
| $23M | 0.06% |
148,492
-20,690
| -12% | -$3.27M |
|
355
Kraft Heinz
KHC
$30.5B
| $22.9M | 0.06% |
719,632
+7,500
| +1% | +$225K |
|
|
BLUE
356
DELISTED
bluebird bio
BLUE
| $22.9M | 0.06% |
28,940
-71,852
| -71% | -$54.2M |
|
|
XLNX
357
DELISTED
Xilinx Inc
XLNX
| $22.8M | 0.06% |
232,050
+1,900
| +0.8% | +$169K |
|
358
Celldex Therapeutics
CLDX
$3.22B
| $22.8M | 0.06% |
+1,750,000
| New | +$7.76M |
|
|
SIVB
359
DELISTED
SVB Financial Group
SIVB
| $22.6M | 0.06% |
104,800
-202,000
| -66% | -$38.9M |
|
360
Semtech
SMTC
$11.3B
| $22.6M | 0.06% |
432,127
+235,560
| +120% | +$11M |
|
361
Corteva
CTVA
$52.5B
| $22.5M | 0.06% |
838,857
-14,400
| -2% | -$375K |
|
|
PPL
362
PPL Corp
PPL
$26.5B
| $22.5M | 0.06% |
869,125
-462,893
| -35% | -$12M |
|
363
PACCAR
PCAR
$70.2B
| $22.3M | 0.06% |
447,293
-1,182,790
| -73% | -$55.3M |
|
364
Revvity
RVTY
$12.8B
| $22.3M | 0.06% |
227,535
+99,632
| +78% | +$9.11M |
|
|
AZEK
365
DELISTED
The AZEK Co
AZEK
| $22.3M | 0.06% |
+700,000
| New | +$21.3M |
|
366
Mettler-Toledo International
MTD
$28.5B
| $22.3M | 0.06% |
27,654
-19,800
| -42% | -$14.7M |
|
367
BorgWarner
BWA
$13.7B
| $22.2M | 0.06% |
715,232
+336,028
| +89% | +$8.85M |
|
368
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $22.1M | 0.06% |
907,025
-144,827
| -14% | -$3.16M |
|
369
MarketAxess Holdings
MKTX
$5.71B
| $22M | 0.06% |
43,850
+400
| +0.9% | +$186K |
|
|
TCF
370
DELISTED
TCF Financial Corporation Common Stock
TCF
| $22M | 0.06% |
746,380
-81,313
| -10% | -$2.24M |
|
371
Hershey
HSY
$36.1B
| $21.8M | 0.06% |
167,885
+1,000
| +0.6% | +$134K |
|
372
Prudential Financial
PRU
$41.5B
| $21.6M | 0.06% |
354,037
+17,900
| +5% | +$1.05M |
|
373
Church & Dwight Co
CHD
$24.6B
| $21.5M | 0.06% |
277,774
+2,400
| +0.9% | +$175K |
|
374
Entergy
ETR
$49.9B
| $21.1M | 0.05% |
450,102
-407,042
| -47% | -$19.8M |
|
375
D.R. Horton
DHI
$42.4B
| $20.9M | 0.05% |
377,700
-6,100
| -2% | -$296K |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.